IL2 and COVID-19: Overall, we found an increase in anti-SARS-CoV-2 serum antibody levels over time and no decrease in IL-2- or IFN-γ-producing cells, which suggests maintenance of a robust functional immune system post-COVID-19 in patients with and without long COVID.